Oxycodone and Aspirin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mayne Pharma Inc.. The primary component is Oxycodone Hydrochloride; Aspirin.
| Product ID | 68308-845_0fa56226-3a68-4951-a958-2acde03d3cdf |
| NDC | 68308-845 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Oxycodone and Aspirin |
| Generic Name | Oxycodone Hydrochloride And Aspirin |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-05-02 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA091670 |
| Labeler Name | Mayne Pharma Inc. |
| Substance Name | OXYCODONE HYDROCHLORIDE; ASPIRIN |
| Active Ingredient Strength | 5 mg/1; mg/1 |
| Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2011-05-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA091670 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-05-02 |
| Ingredient | Strength |
|---|---|
| OXYCODONE HYDROCHLORIDE | 4.8355 mg/1 |
| SPL SET ID: | 3848642e-cc9e-4150-8199-281b294c18bc |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| Pharm Class PE | |
| PHarm Class EPC | |
| UPC Code | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0591-3551 | Oxycodone and Aspirin | Oxycodone and Aspirin |
| 68308-845 | Oxycodone and Aspirin | Oxycodone Hydrochloride and Aspirin |